For mAbs A Small Biotech Recognizes The Value Of Expertise And Track Record
See how reputation for quality and experience with antibodies were driving forces in the CDMO selection for a CPI-006 antibody program.
Stay updated with breaking news from Pharmaceutical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
See how reputation for quality and experience with antibodies were driving forces in the CDMO selection for a CPI-006 antibody program.
/PRNewswire/ -- The "2022 Global Drug Bioavailability Enhancement Summit" conference has been added to ResearchAndMarkets.com's offering. Are you tasked with...
Conference Call and Live Audio Webcast Scheduled for Monday, March 28, 2022, at 10:00 a.m. ET Corporate Highlights Reconstituted Board and appointed Wendy...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
New York, NY, March 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based...